ACCD Dec 2024 5.000 put
- Simply Wall St.
Accolade First Quarter 2025 Earnings: Beats Expectations
Accolade ( NASDAQ:ACCD ) First Quarter 2025 Results Key Financial Results Revenue: US$110.5m (up 19% from 1Q 2024). Net...
- Barrons.com
Accolade Stock on Pace for All-Time Low as Guidance Disappoints. The Case to Buy the Dip.
Accolade stock was falling sharply after its earnings report disappointed. Analyst Jack Wallace lowered his price target on the tech and health company to $6 from $13, while maintaining a Buy rating on the stock. Wallace added the optimism was fueled by his belief that the stock’s valuation is at a bottom, and management’s lowering of its fiscal-year guidance is a “clearing of the decks move that should allow ACCD to at least meet, if not exceed, guidance for the rest of the year.”
- Insider Monkey
Accolade, Inc. (NASDAQ:ACCD) Q1 2025 Earnings Call Transcript
Accolade, Inc. (NASDAQ:ACCD) Q1 2025 Earnings Call Transcript June 27, 2024 Accolade, Inc. beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.48. Operator: Hello, and thank you for standing by. Welcome to the Accolade First Quarter 2025 Earnings Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ […]
